# RSV temporally reprograms apoptosis and pyroptosis to balance immune evasion and replication

**Authors:** Cong Liu, Haiwu Zhou, Jian Li, Yang Meng, Jingyu Wang, Mingbin He, Weiwei Wang, Zhifei Li, Yali Qin, Mingzhou Chen

PMC · DOI: 10.1126/sciadv.adz2496 · Science Advances · 2026-01-23

## TL;DR

RSV manipulates cell death pathways over time to hide from the immune system and spread efficiently in the lungs.

## Contribution

RSV uses a timed strategy to control apoptosis and pyroptosis for immune evasion and replication.

## Key findings

- RSV suppresses apoptosis early using PI3K-Akt and cFLIP to avoid immune detection.
- RSV prevents pyroptosis by degrading ZDHHC9, allowing viral replication.
- Late-stage RSV triggers apoptosis and pyroptosis to release viruses and worsen lung damage.

## Abstract

Virus-induced inflammation and programmed cell death (PCD) are critical antiviral defenses, prompting viruses like respiratory syncytial virus (RSV) to develop PCD regulation mechanisms. Here, we demonstrate that RSV orchestrates the temporal and sequential regulation of distinct PCD pathways in human macrophages to optimize replication and dissemination. During early stages of infection, RSV activates the PI3K-Akt pathway to induce cFLIP expression, effectively suppressing TNF-driven extrinsic apoptosis. Simultaneously, viral degradation of ZDHHC9 prevents GSDMD-mediated pyroptosis downstream of NLRP3 activation, thereby sustaining an intracellular environment permissive to viral propagation. In contrast, following the completion of replication, RSV subverts caspase-1 signaling to trigger the intrinsic apoptotic cascade via the Casp-1–BID–APAF1–Casp-9 axis, and subsequently promotes GSDME-mediated secondary pyroptosis. This late-stage PCD reprogramming enables synchronized release of virions and pro-inflammatory cytokines, exacerbating pulmonary pathology. These findings delineate a temporally resolved strategy by which RSV balances early immune evasion with subsequent viral dissemination and immunopathology, and identify discrete stage-specific molecular targets for therapeutic intervention in RSV-induced lung disease.

RSV orchestrates cell death and IL-1β release via spatially distinct, linked death signaling axes for immune evasion and spread.

## Linked entities

- **Genes:** PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], CFLAR (CASP8 and FADD like apoptosis regulator) [NCBI Gene 8837], ZDHHC9 (zDHHC palmitoyltransferase 9) [NCBI Gene 51114], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], GSDMD (gasdermin D) [NCBI Gene 79792], CASP1 (caspase 1) [NCBI Gene 834], BID (BH3 interacting domain death agonist) [NCBI Gene 637], APAF1 (apoptotic peptidase activating factor 1) [NCBI Gene 317], CASP9 (caspase 9) [NCBI Gene 842], GSDME (gasdermin E) [NCBI Gene 1687]
- **Diseases:** lung disease (MONDO:0005275)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, CASP7 (caspase 7) [NCBI Gene 840] {aka CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, NLRP1 (NLR family pyrin domain containing 1) [NCBI Gene 22861] {aka AIADK, CARD7, CIDED, CLR17.1, DEFCAP, DEFCAP-L/S}, TICAM1 (TIR domain containing adaptor molecule 1) [NCBI Gene 148022] {aka IIAE6, MyD88-3, PRVTIRB, TICAM-1, TRIF}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, CFLAR (CASP8 and FADD like apoptosis regulator) [NCBI Gene 8837] {aka CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1}, AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, FASLG (Fas ligand) [NCBI Gene 356] {aka ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, ZDHHC5 (zDHHC palmitoyltransferase 5) [NCBI Gene 25921] {aka DHHC5, ZNF375}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, TPPP3 (tubulin polymerization promoting protein family member 3) [NCBI Gene 51673] {aka CGI-38, TPPP/p20, p20, p25gamma}, CASP10 (caspase 10) [NCBI Gene 843] {aka ALPS2, FLICE-2, FLICE2, MCH4}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, FAM72B (family with sequence similarity 72 member B) [NCBI Gene 653820] {aka p17}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, FLT3LG (fms related receptor tyrosine kinase 3 ligand) [NCBI Gene 2323] {aka FL, FLG3L, FLT3L, IMD125}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, XIAP (X-linked inhibitor of apoptosis) [NCBI Gene 331] {aka API3, BIRC4, IAP-3, ILP1, MIHA, XLP2}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, CRTAP (cartilage associated protein) [NCBI Gene 10491] {aka CASP, LEPREL3, OI7, P3H5}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, TRADD (TNFRSF1A associated via death domain) [NCBI Gene 8717] {aka Hs.89862}, APAF1 (apoptotic peptidase activating factor 1) [NCBI Gene 317] {aka APAF-1, CED4}, MAGT1 (magnesium transporter 1) [NCBI Gene 84061] {aka CDG1CC, IAP, MRX95, OST3B, PRO0756, SLC58A1}, BID (BH3 interacting domain death agonist) [NCBI Gene 637] {aka FP497}, ZDHHC17 (zDHHC palmitoyltransferase 17) [NCBI Gene 23390] {aka DHHC-17, DHHC17, HIP14, HIP3, HSPC294, HYPH}, AIMP1 (aminoacyl tRNA synthetase complex interacting multifunctional protein 1) [NCBI Gene 9255] {aka EMAP2, EMAPII, HLD3, SCYE1, p43}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, ZDHHC9 (zDHHC palmitoyltransferase 9) [NCBI Gene 51114] {aka CGI89, CXorf11, DHHC9, MMSA1, MRXSR, MRXSZ}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, PHB2 (prohibitin 2) [NCBI Gene 11331] {aka BAP, BCAP37, Bap37, PNAS-141, REA, hBAP}, BIRC3 (baculoviral IAP repeat containing 3) [NCBI Gene 330] {aka AIP1, API2, CIAP2, HAIP1, HIAP1, IAP-1}
- **Diseases:** infected (MESH:D007239), bronchitis (MESH:D001991), inflammatory cytopathy (MESH:C540770), respiratory infection (MESH:D012141), Viral infection (MESH:D014777), complications (MESH:D008107), PCD (MESH:D003643), respiratory diseases (MESH:D012140), RSV (MESH:D018357), bronchiolitis (MESH:D001988), fever (MESH:D005334), lung disease (MESH:D008171), inflammation (MESH:D007249), nasal congestion (MESH:D009668), lung inflammation (MESH:D011014)
- **Chemicals:** N (MESH:D009584), SDS (MESH:D012967), polybrene (MESH:D006583), LY294002 (MESH:C085911), PMA (MESH:D013755), MG132 (MESH:C072553), Alexa Fluor 488 (MESH:C000711379), TRIzol (MESH:C411644), CQ (MESH:D002738), poly(dA:dT) (MESH:D011067), Nav (MESH:C528561), bromophenol blue (MESH:D001978), necrostatin-1 (MESH:C507699), SM-164 (MESH:C533467), 4',6-diamidino-2-phenylindole (MESH:C007293), dextran sulfate sodium (MESH:D016264), Nig (MESH:D009550), Bir (MESH:C582429), Dulbecco's modified Eagle's medium (-), 5z-7-oxozeaenol (MESH:C505734), phenylmethylsulfonyl fluoride (MESH:D010664), puromycin (MESH:D011691), Alexa Fluor 647 (MESH:C569686), streptomycin (MESH:D013307), EDTA (MESH:D004492), Hoechst 33342 (MESH:C017807), DMSO (MESH:D004121), VX765 (MESH:C520022), wortmannin (MESH:D000077191), Triton X-100 (MESH:D017830), paraformaldehyde (MESH:C003043), Tween 20 (MESH:D011136), penicillin (MESH:D010406), ATP (MESH:D000255), glycerol (MESH:D005990), Z-VAD-FMK (MESH:C096713), Cis (MESH:D002945), Bort (MESH:D000069286), Z-AEVD-FMK (MESH:C470795), PEG6000 (MESH:C000595215), dithiothreitol (MESH:D004229), Sytox Green (MESH:C402795), CO2 (MESH:D002245), Z-LEHD-FMK (MESH:C403754), blasticidin S (MESH:C004500), LPS (MESH:D008070), NaCl (MESH:D012965), 3-MA (MESH:C025946), CHX (MESH:D003513), Fer-1 (MESH:C573944), MCC950 (MESH:C000597426)
- **Species:** Human respirovirus 3 (no rank) [taxon 11216], human respiratory syncytial virus (no rank) [taxon 11250], Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814]
- **Mutations:** G to I, A to E, (H) to (K), A to D, D to F, I to L, A to G, E to H, F to K, L to P, A to C, His-Cys-9, initiation at position 1, A to I
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), THP-1 macrophages — Labeo rohita (Indian major carp), Spontaneously immortalized cell line (CVCL_A8VR), TIB-202 — Sarcophilus harrisii (Tasmanian devil), Devil facial tumor disease 2, Cancer cell line (CVCL_LB80), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059), BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168), PMA — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_1081), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HEp-2 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_1906)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829576/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829576/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12829576/full.md

---
Source: https://tomesphere.com/paper/PMC12829576